MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics, Inc. (MPLT)

|||

Balance Sheets Overview

Current Ratio
1652.26%
Quick Ratio
1652.26%
Cash Ratio
371.27%
Debt to Asset Ratio
5.44%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Long-term investments
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
71,633
55,707
46,729
64,146
Short-term investments
233,092
254,406
258,374
163,022
Prepaid expenses and other current assets
14,063
17,115
19,567
18,138
Total current assets
318,788
327,228
324,670
245,306
Total property and equipment
-
-
3,734
3,359
Less accumulated depreciation
-
-
2,639
2,500
Property and equipment, net
828
968
1,095
859
Long-term investments
46,616
85,090
147,993
-
Restricted cash
207
207
207
207
Right of use asset
1,668
5,259
5,488
5,710
Other assets
241
36
59
5,140
Total assets
368,348
418,788
479,512
257,222
Redeemable convertible preferred stock-Series DRedeemable Convertible Preferred Stock
-
-
0
198,870
Redeemable convertible preferred stock-Series CRedeemable Convertible Preferred Stock
-
-
0
224,992
Redeemable convertible preferred stock-Series B1Redeemable Convertible Preferred Stock
-
-
0
11,981
Redeemable convertible preferred stock-Series BRedeemable Convertible Preferred Stock
-
-
0
51,094
Redeemable convertible preferred stock-Series A1Redeemable Convertible Preferred Stock
-
-
0
15,963
Redeemable convertible preferred stock-Series ARedeemable Convertible Preferred Stock
-
-
0
4,793
Accounts payable
2,052
3,188
3,289
2,446
Accrued expenses
16,010
10,175
12,049
14,048
Lease liability - current
1,232
920
891
862
Deferred grant earnings
-
-
0
1,206
Total current liabilities
19,294
14,283
16,229
18,562
Lease liability - noncurrent
755
4,671
4,911
5,144
Total long-term liabilities
-
-
-
5,144
Total liabilities
20,049
18,954
21,140
23,706
Common stock, 0.0001 par value per share 500,000,000 shares authorized at june 30, 2026 and december 31, 2025 45,436,867 and 44,024,088 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
5
5
5
-
Additional paid-in-capital
830,618
821,900
819,115
6,749
Accumulated other comprehensive loss
-944
-883
-228
46
Accumulated deficit
-481,380
-421,188
-360,520
-280,972
Total stockholders' equity
348,299
399,834
458,372
-274,177
Total liabilities and stockholders' equity
368,348
418,788
479,512
257,222
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$233,092K Cash and cashequivalents$71,633K Prepaid expenses andother current assets$14,063K Total current assets$318,788K Long-term investments$46,616K Right of use asset$1,668K Property and equipment,net$828K Other assets$241K Restricted cash$207K Total assets$368,348K Total liabilities andstockholders' equity$368,348K Total stockholders'equity$348,299K Total liabilities$20,049K Accumulated deficit-$481,380K Accumulated othercomprehensive loss-$944K Additionalpaid-in-capital$830,618K Total currentliabilities$19,294K Lease liability -noncurrent$755K Common stock, 0.0001par value per share...$5K Accrued expenses$16,010K Accounts payable$2,052K Lease liability -current$1,232K